The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Multiplex Biomarker Imaging Market From 2026 To 2030?
The multiplex biomarker imaging market has seen significant expansion in recent years. Its valuation is projected to increase from $0.54 billion in 2025 to $0.6 billion in 2026, registering a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to an upsurge in cancer research studies, a greater demand for biomarker-driven analysis, the initial integration of fluorescence imaging, the limitations of single-marker analysis techniques, and the proliferation of molecular pathology testing.
The multiplex biomarker imaging market is projected to experience robust growth in the upcoming years, with its size expected to reach $0.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. This expansion during the forecast period can be attributed to advancements in imaging platforms, an increasing demand for personalized medicine, the broadening use of multiplex assay applications, the growth of pharmaceutical biomarker programs, and heightened investment in spatial biology research. Key trends anticipated in this period include the expanding application of multiplex imaging in oncology research, a rising demand for high-resolution tissue mapping, the increased adoption of advanced immunofluorescence techniques, the proliferation of automated image analysis solutions, and the integration of multiplex imaging with drug discovery platforms.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16127&type=smp
What Key Drivers Are Fueling The Growth Of The Multiplex Biomarker Imaging Market?
The increasing incidence of chronic diseases is projected to drive the expansion of the multiplex biomarker imaging market moving forward. These are long-lasting health conditions that endure or reappear, often involving complex etiologies, multiple risk factors, and extended incubation periods. The growing occurrence of chronic diseases stems from various factors, including the rapid aging of the population, improved identification and diagnosis, enhanced disease treatment and management, and modifications in lifestyle and environmental risk factors. Multiplex biomarker imaging plays a crucial role in chronic disease management, facilitating comprehensive analysis and characterization of disease progression and responses to therapy. As an illustration, a report published in January 2023 by the National Institutes of Health (NIH), a US-based biomedical research agency, forecasts that the population aged 50 and older with at least one chronic illness will increase by 99.5%, from 71.52 million in 2020 to 142.66 million in 2050. This surge in chronic disease prevalence is thus propelling the growth of the multiplex biomarker imaging market.
How Is The Multiplex Biomarker Imaging Market Organized By Segment Classification?
The multiplex biomarker imaging market covered in this report is segmented –
1) By Component Type: Instruments, Software, Services
2) By Imaging Techniques: Immunofluorescence (IF) Assay, Tissue Microarray (TMA) Assay, Immunohistochemistry (IHC) Assay, Fluorescent In Situ Hybridization (FISH) Assay, Toponome Imaging System (TIS)
3) By Application: Drug Safety, Oncology Studies, Genetic Characterization Studies
4) By End User: Research Institutes, Government And Private, Clinical Labs, Pharmaceutical And Biotechnology
Subsegments:
1) By Instruments: Imaging Systems (Microscopes, Scanners), Detection Devices, Reagents And Kits
2) By Software: Image Analysis Software, Data Management Software, Visualization And Interpretation Software
3) By Services: Technical Support And Maintenance, Consultation And Training, Imaging And Analysis Services
What Trends Are Influencing The Multiplex Biomarker Imaging Market?
Companies operating in the multiplex biomarker imaging market are prioritizing the development of innovative slides, including automated slide loaders, to provide advanced imaging solutions and enhance customer service. Automated slide loaders optimize sample handling, significantly reducing manual effort and boosting throughput, which is essential for high-volume multiplex biomarker imaging experiments. For example, in April 2024, Standard BioTools Inc., a US-based provider of analytical systems and instruments, introduced a Hyperion XTi Imaging System featuring a new high-throughput multiplexed whole slide to incorporate automation and flexibility. This system offers three modes for rapid analysis: preview, tissue, and cell, enabling researchers to quickly visualize tissue heterogeneity and perform deeper analysis. This novel whole slide imaging method, utilizing imaging mass cytometry (IMC), achieves up to 10 times higher throughput than cyclic immunofluorescent imaging. Additionally, a new automated slide loader facilitates high-throughput imaging, cutting down hands-on time and allowing for standardization. These advancements aim to accelerate breakthroughs in spatial proteomics, delivering dependable insights into health and disease.
Who Are The Industry Participants Involved In The Multiplex Biomarker Imaging Market?
Major companies operating in the multiplex biomarker imaging market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company (BD), Carl Zeiss AG, Illumina Inc, PerkinElmer Inc., Bio-Rad Laboratories Inc, Bruker Corporation, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Abcam Plc, Meso Scale Diagnostics LLC, Fluidigm Corporation, NanoString Technologies, Quanterix Corporation, Akoya Biosciences, Enzo Biochem Inc, Cisbio Bioassays, Flagship Biosciences, Aushon BioSystems Ltd, Ionpath Inc., Biosims Technologies
Get The Full Multiplex Biomarker Imaging Market Report:
https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report
Which Region Has The Greatest Market Share In The Multiplex Biomarker Imaging Market?
North America was the largest region in the multiplex biomarker imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex biomarker imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Multiplex Biomarker Imaging Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report
Browse Through More Reports Similar to the Global Multiplex Biomarker Imaging Market 2026, By The Business Research Company
Multiplex Pcr Assays Market Report 2026
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report
Multiplex Biomarker Imaging Market Report
https://www.thebusinessresearchcompany.com/report/multiplex-biomarker-imaging-global-market-report
Cell Based Assays Market Report
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model